Embecta (NASDAQ:EMBC) Issues Earnings Results, Beats Estimates By $0.43 EPS

Embecta (NASDAQ:EMBCGet Rating) announced its quarterly earnings data on Monday. The company reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.43, Fidelity Earnings reports. The company had revenue of $291.10 million for the quarter.

Embecta Stock Up 2.2 %

NASDAQ:EMBC opened at $33.39 on Friday. Embecta has a one year low of $23.62 and a one year high of $49.00. The firm’s fifty day moving average is $27.77.

Embecta Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 14th. Investors of record on Friday, August 26th will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 1.80%. The ex-dividend date is Thursday, August 25th.

Wall Street Analyst Weigh In

EMBC has been the subject of a number of analyst reports. Bank of America assumed coverage on shares of Embecta in a research note on Tuesday, June 21st. They issued an “underperform” rating and a $25.00 target price for the company. Morgan Stanley boosted their price objective on shares of Embecta from $33.00 to $36.00 and gave the stock an “equal weight” rating in a research note on Tuesday.

About Embecta

(Get Rating)

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally.

Further Reading

Receive News & Ratings for Embecta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embecta and related companies with MarketBeat.com's FREE daily email newsletter.